MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹2,120 Cr | ₹1,863 Cr | ₹2,623 Cr | ₹1,353 Cr | ₹1,251 Cr |
What is the latest Total Current Liabilities ratio of MANKIND PHARMA ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹2,120 Cr |
Mar2023 | ₹1,863 Cr |
Mar2022 | ₹2,623 Cr |
Mar2021 | ₹1,353 Cr |
Mar2020 | ₹1,251 Cr |
How is Total Current Liabilities of MANKIND PHARMA Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹2,120 Cr | 13.77 | |
Mar2023 | ₹1,863 Cr | -28.98 | |
Mar2022 | ₹2,623 Cr | 93.84 | |
Mar2021 | ₹1,353 Cr | 8.21 | |
Mar2020 | ₹1,251 Cr | - |
Compare Total Current Liabilities of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹98,144.2 Cr | 0.7% | -6.7% | 10.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,824.0 Cr | 0.5% | -0.5% | 14.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,355.0 Cr | 1.3% | 10.7% | 49.3% | Stock Analytics | |
CIPLA | ₹122,929.0 Cr | 2.2% | 0.2% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,701.0 Cr | 4.7% | 11.9% | 14.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹108,502.0 Cr | 2% | -0.8% | 15.7% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | 0.7% |
-6.7% |
10.3% |
SENSEX | 1.9% |
0.1% |
10.9% |
You may also like the below Video Courses